Pneumonia kills two lakh children in India every year, but the vaccine has so far been available only in the private market at a high price.
Anoo Bhuyan covers health policy for The Wire. Before this she worked at Outlook Magazine, National Public Radio and BBC. She did her postgraduate degree in Conflict and Development Studies from SOAS, University of London. She tweets at @AnooBhu and archives her work at www.anoobhuyan.wordpress.com
The Swadeshi Jagran Manch has accused the pharmaceutical department of undermining the National Pharmaceutical Pricing Agency and diluting its powers.
The policy proposes a reversal to “monitoring” the prices of drugs, instead of “controlling” them, although the Supreme Court had earlier ruled against this.
“One can keep blaming us for things but this is an exercise which has been neglected for the last 20 years in the state of UP, Bihar, Assam,” UP health minister Siddharth Nath Singh said.
With the government giving 23 natural reasons for the children’s deaths, the official line eliminates any human or institutional hand or negligence.
The UP government insists that the deaths are unrelated to any oxygen shortage, though they are yet to explain why 23 children died on August 10.
A committee working under the ministry has written to a Nobel laureate, academics and governments countering their criticisms of homeopathy.
The Centre’s pharmaceutical pricing agency has issued a demand-notice for Rs 1,26,547 from a Haryana hospital, which sources say is the first of many more recoveries.
The negotiator’s comments were non-committal but indicated that for now, the RCEP talks have not yet moved decisively into a TRIP-plus scenario.
Worried about the impact of the trade negotiations, a consortium of civil groups called the People’s Resistance Forum has asked for the talks to be called off.
The Tamil Nadu government conducted three tests in different states before confirming the positive case of Zika virus.
Of the 134 cases that India reported, the cause of death among 96% of children was listed as being “unclassifiable” or “coincidental due to something other than vaccine.”
In their letter, many individuals and organisations stated that a country with as much poverty as India should not enforce patents on drugs and vaccines the same way industrialised countries have.
The public interest litigation seeks the divestment of 32% shares held by public sector insurance companies in the tobacco major ITC.
Until the new notification making Aadhaar compulsory under the government’s Revised National Tuberculosis Control Programme, healthcare workers say did not even know cash benefits were available.
In 2012, the BJP’s presidential nominee testified in support of former BJP president Bangaru Laxman, who was eventually convicted of corruption.
Even as the Indian Medical Association head claims he was unaware of the polarising VHP leader’s past, others say he could help doctors gain attention to their demands.
India was moved up from the safest category 4 to category 2 in WHO’s country-classification table for the Zika virus.
Indian officials say there was no responsibility to inform the WHO about the three Zika cases, while the WHO says this is not true.
While the Integrated Disease Surveillance Programme reports in detail about food poisoning, cholera and even Crimean-Congo hemorrhagic fever, it has reported zero cases of Zika, though the government and WHO confirmed three cases.
In November 2016, the Delhi high court had ordered the government to finalise a policy on rare disease as patients repeatedly petitioned the court asking that the expensive drugs required for treatment be provided for free.
NITI Aayog’s research on drug deregulation continues unabated, even as two Union ministers have said they will follow the prime minister’s vision on affordable healthcare.
The government’s premier policy-formulating agency recently recommended measures to deregulate the pharmaceutical sector and make essential medicines more expensive.
Swadeshi Jagran Manch has accused several government arms of lobbying for pharmaceutical companies and negating the NPPA’s attempts to make medicines affordable.
India’s drug controller is allowing Abbott’s coronary stent, Absorb BVS, to start fresh clinical trials, though it has been red-flagged by the US and Australia.
As the agitation in Manipur’s hill district crosses its 600th day and eight bodies still await burial, the protesters witnessed their struggle nearly reach a resolution this month, but then suddenly head back into a deadlock.
With fake news proliferating on social media, journalists and news organisations in the US and Europe are collaborating to come up with a counter-strategy.
At the Supreme Court’s asking, a rights group in Manipur is sorting through files pertaining to over 1,528 victims of alleged extra-judicial killings to place before the judges.
Although using the drug enables dairy and horticulture farmers to gain more profits, it puts both their livestock and consumers at great risk.
In a wide-ranging interview with The Wire, the outgoing secretary of the AYUSH ministry, Ajit M. Sharan, says the rules to the Drugs and Cosmetics Act will soon be changed to have strict guidelines for safety trials of AYUSH medicines.
The debate and discussion that went into this Bill stand in stark contrast to other recent ‘backdoor’ parliamentary decisions, such as the Finance Bill.
Solidarity Grows for Maharashtra’s Agitating Doctors Ahead of Meet With Fadnavis Over Security Issues
Doctors across Maharashtra and in other places have been on strike, protesting against the lack of security in hospitals and attacks on medical professionals.
The Bill was passed without amending the contentious clause that puts no legal obligation on the state if a patient is denied treatment.
Explaining what ‘non-governmental’ means, two bureaucrats clarified it meant both NGOs as commonly understood as charitable organisations as well as private for-profit organisations.
The new policy unveiled in parliament also envisages an increase in the health budget to 2.5% of GDP but only by 2025.